Rosacea can be unsettling, uncomfortable, and painful. MetroBoston is planning Rosacea Clinical Trials In Boston to understand the skin condition and find its potential treatments.
Rosacea Clinical Trials
Rosacea is a chronic skin condition that primarily affects the face, causing redness, flushing, and visible blood vessels. It can also cause pimples, bumps, and a thickening of the skin on the nose, leading to a condition called rhinophyma. Rosacea typically affects more women than men. The prevalence of rosacea is estimated to be around 1-10% worldwide. In the United States, it is estimated that rosacea affects approximately 16 million people. MetroBoston is conducting rosacea clinical trials to determine the safety and efficacy of potential new treatments that may improve Rosacea and therefore quality of life in those suffering from Rosacea.